{"count": 1, "results": [{"_id": "28294798", "pmid": 28294798, "title": "[Safety and Efficacy of Amlodipine, Lisinopril and Rosuvastatin Therapy in Patients With Metabolic Syndrome and Nonalcoholic Fatty Liver Disease].", "journal": "Kardiologiia", "authors": ["Baranova EI", "Berezina AV", "Melioranskaya EI", "Polyakova EA"], "date": "2015-10-01T00:00:00Z", "doi": "10.18565/cardio.2015.10.68-75", "meta_date_publication": "2015 Oct", "meta_volume": "55", "meta_issue": "10", "meta_pages": "68-75", "score": 50061.43, "text_hl": "AIM: To evaluate the efficacy and safety of amlodipin, @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ and @CHEMICAL_Rosuvastatin_Calcium @CHEMICAL_MESH:D000068718 @@@rosuvastatin@@@ therapy in @DISEASE_Metabolic_Syndrome @DISEASE_MESH:D024821 @@@metabolic syndrome@@@ and high cardiovascular risk @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Non_alcoholic_Fatty_Liver_Disease</m> @DISEASE_MESH:D065626 @@@nonalcoholic fatty liver disease@@@ (@<m>DISEASE_Non_alcoholic_Fatty_Liver_Disease</m> @DISEASE_MESH:D065626 @@@NAFLD@@@). ", "citations": {"NLM": "Baranova EI, Berezina AV, Melioranskaya EI, Polyakova EA. [Safety and Efficacy of Amlodipine, Lisinopril and Rosuvastatin Therapy in Patients With Metabolic Syndrome and Nonalcoholic Fatty Liver Disease]. Kardiologiia. 2015 Oct;55(10):68-75. PMID: 28294798", "BibTeX": "@article{28294798, title={[Safety and Efficacy of Amlodipine, Lisinopril and Rosuvastatin Therapy in Patients With Metabolic Syndrome and Nonalcoholic Fatty Liver Disease].}, author={Baranova EI and Berezina AV and Melioranskaya EI and Polyakova EA}, journal={Kardiologiia}, volume={55}, number={10}, pages={68-75}}"}}]}